Ahmed M. Hamdy's Insider Trades & SAST Disclosures
Ahmed M. Hamdy's most recent trade in Vincerx Pharma Inc was a trade of 146,746 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ahmed M. Hamdy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 146,746 | 146,746 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 146,746 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 127,500 | 127,500 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 127,500 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 90,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 60,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 60,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 53,254 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 53,254 | 200,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 53,254 | 200,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 146,746 | 146,746 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 09 Aug 2023 | 16,900 | 90,660 | - | 0.9 | 15,994 | Common Stock |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 09 Aug 2023 | 5,400 | 96,060 | - | 1.0 | 5,167 | Common Stock |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 14 Dec 2022 | 35,280 | 73,760 | - | 0.9 | 30,538 | Common Stock |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 23 Jun 2022 | 24,200 | 38,480 | - | 1.4 | 34,137 | Common Stock |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 127,500 | 127,500 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.02 per share. | 22 Dec 2021 | 6,450 | 14,280 | - | 10.0 | 64,650 | Common Stock |
| Vincerx Pharma Inc | Ahmed M. Hamdy | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 12.77 per share. | 29 Jun 2021 | 7,830 | 7,830 | - | 12.8 | 99,989 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges